Fig. 2.
Depicts the time to recover granulocytes to ≥0.5 × 109/L and platelets to ≥50 × 109/L for the eight patients who received CD34+Thy1+ Lin− cells compared with that of 128 control patients with ≤12 months of preceding standard chemotherapy who received unmanipulated PBSC mobilized with the same regimen.